News

Retirement

15 Ways to Make More Money in Your 401(K)

15 Ways to Make More Money in Your 401(K)

Paul Merriman | Equities.com |

For many people, a 401(k) retirement plan is the biggest source of retirement savings. Unfortunately, most people don’t use their retirement funds to the best advantage.


What to Do If You Make Too Much to Contribute to a Roth IRA

IRIS.xyz | Equities.com |

Roth IRAs come with income caps. Here's what to do if you are above the limit.


Canada's Pensions in Great Shape?

Leo Kolivakis | Equities.com |

Canada's large pensions are good shape because they properly manage assets and liabilities, and have the right governance to attract and retain world-class investment managers.


How Does Your Stock Allocation Compare to Your Peers?

Benjamin | Equities.com |

How much of your assets should be in stocks?


Save $1,000 a Year. Retire with Millions.

Paul Merriman | Equities.com |

By saving less than $100 a month, adjusting the savings for inflation, and investing well, a young person can retire with millions.


Is Social Security Really Just Welfare in Disguise?

Patrick Watson | Equities.com |

The core problem is that Social Security benefits are more generous than the taxes collected can cover.


​Where Are You on the Path to Retirement?

Harry Dent | Equities.com |

Even if you love your job and have no immediate plans to stop working, there is a certain peace of mind in knowing you can walk away when the time comes.


Europe’s Pension Funds Are Running Low as Boomers Retire

John Mauldin | Equities.com |

Europe has the largest population of pensioners that continues to grow.


Over 60% of Americans Don't Know What They Need to Retire

Due | Equities.com |

A huge number of Americans have little to no retirement savings. Let’s look at some important retirement savings rules to make sure you are not part of this scary statistic.


Retirement Is Globally Dead

John Mauldin | Equities.com |

The main driver of this problem is increasing life expectancies.


Emerging Growth

IMV Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.

Events

The MoneyShow San Francisco

Why should you join thousands of America's savviest investors and traders who make The MoneyShow San Francisco their can't-miss conference each summer? Because you will meet face-to-face and hear from…

Learn more